Vascular Effects of Endothelium-Derived Versus Hemoglobin-Transported Nitric Oxide in Healthy Subjects
Diabetes Mellitus, Healthy, Hypercholesterolemia
About this trial
This is an interventional treatment trial for Diabetes Mellitus focused on measuring Blood Flow, Exercise, Microcirculation, S-nitrosohemoglobin, Vasodilation, Healthy Volunteer
Eligibility Criteria
All volunteer subjects must be between 21 and 75 years of age, in good health, and must have provided informed, written consent for participation in this study. No subjects with a history or evidence of present or past hypertension (blood pressure greater than 145/95 mmHg), hypercholesterolemia (LDL cholesterol greater than 130 mg/dL), diabetes mellitus (fasting blood glucose greater than 120 mg/dL), smoking within 2 years, cardiac disease, peripheral vascular disease, coagulopathy, or any other disease predisposing to vasculitis or Raynaud's phenomenon. No volunteer subject will be allowed to take any medication (oral contraceptive agents are allowed) or vitamin supplements for at least one month prior to study and will not be allowed to take aspirin for one week prior to study. Pregnancy testing will be required of all women of reproductive age to exclude current pregnancy.
Sites / Locations
- National Heart, Lung and Blood Institute (NHLBI)